GSTT2 Switches from a Homeostatic Antioxidant to a Cell-Cycle-Coupled Factor in Therapy-Resistant Esophageal Adenocarcinoma. [PDF]
Ferrer-Torres D +17 more
europepmc +1 more source
Development of an Orthotopic Patient-Derived Xenograft Model of Gastro-Esophageal Adenocarcinoma: A Single-Lineage Pilot Study. [PDF]
Reddavid R +4 more
europepmc +1 more source
Acidic bile salt‑induced DNA methylation promotes APE1 upregulation through miR‑128‑3p silencing in esophageal adenocarcinoma. [PDF]
Ballout F +11 more
europepmc +1 more source
miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma. [PDF]
Cahill C +25 more
europepmc +1 more source
SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma. [PDF]
Montalbano M +8 more
europepmc +1 more source
Correction: Targeting the CAF-GDF15 axis attenuates AKT-mediated mitochondrial rewiring and chemoradiation resistance in esophageal adenocarcinoma. [PDF]
Fan N +18 more
europepmc +1 more source
Acute Esophageal Necrosis Associated with Esophageal Adenocarcinoma
Darshit Jasoliya +2 more
openaire +3 more sources
Incidental use of angiotensin system inhibitors during neoadjuvant therapy for esophageal adenocarcinoma: an analysis of survival. [PDF]
Lanuti M.
europepmc +1 more source
Advanced esophageal adenocarcinoma in a pediatric patient with Down syndrome: a rare case report and literature review. [PDF]
Alziadan S +3 more
europepmc +1 more source
Screening for Barrett's esophagus and esophageal adenocarcinoma: recent advances and next steps. [PDF]
Leonard D, Thota PN, Sehgal V.
europepmc +1 more source

